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Reactive Angioendotheliomatosis
Naeha Gupta, DO, Richard McClain, MD, and Nektarios Lountzis, MD
Lehigh Valley Health Network, Allentown, PA

HISTORY OF PRESENT ILLNESS: 60 year-old Caucasian male presents

Reactive Angioendotheliomatosis (RAE) is a rare, benign condition that presents
with a cutaneous vascular proliferation with secondary intravascular thrombi
leading to necrosis and infarction of the skin. RAE tends to occur in patients with
coexistent systemic diseases. Clinical presentation demonstrates erythematous
macules, purpuric papules, and purpuric plaques, which can be ulcerated. Lesions
can affect the face or trunk, but tend to target the limbs. The condition favors
middle-aged adults with no gender predilection. Patients may experience
constitutional symptoms, such as fevers and weight loss. Many patients also have
an elevated erythrocyte sedimentation rate. Other laboratory abnormalities can
include thrombocytopenia, anemia, and leukocytosis. Coexistent diseases are
broad in the literature and include infectious diseases, systemic disease, blood
disorders, monoclonal gammopathies, and vascular abnormalities, including severe
peripheral vascular atherosclerotic disease.

with a lesion on his left thigh for three months. The lesion is initially a pink plaque
described to be the size of a lemon with subsequent progression in size, pain and
central crusting. He has no history of similar lesions elsewhere. Patient was
recently evaluated by vascular surgery and was found to have stenosis as well as
occlusion of the left iliac arteries via ultrasound. He is also noted to have had a
stroke, myocardial infarction, and pancreatitis within the last three months.

MEDICAL HISTORY/SURGICAL HISTORY: Deep venous thrombosis of
left distal lower extremity, cholecystectomy, colonoscopy, stroke, hyperlipidemia,
hypertension, myocardial infarction, and pancreatitis

MEDICATIONS: Atorvastatin, duloxetine, levothyroxine, trazodone, clopidogrel,
metoprolol, oxycodone-acetaminophen

PREVIOUS TREATMENTS: Triamcinolone 0.1% ointment twice daily as
needed

CURRENT TREATMENT: Left common femoral endarectomy with bovine

Figure A. Clinical presentation of left thigh.

Figure B. H&E at 4x. Dermal based proliferation of spindle cells.

patch per vascular surgery, local wound care

PHYSICAL EXAMINATION: Pink to red large plaque on the left medial

thigh with a small amount of scale. More centrally, there is firm white induration
of the plaque with dark brown scale crust. The right leg is clear.

LABORATORY DATA: Hemoglobin 11.7 g/dL (12.0-17.0), platelets 418

thousand s/uL (149-390), fibrinogen 503 mg/dL (227-495), and erythrocyte
sedimentation rate 36 mm/hr (0-11)

On histopathology, the individual lesions can vary. Histopathologic examination
shows dilated vessels in the dermis and upper subcutaneous fat, filled with cells
and fibrin, sometimes leading to vascular occlusion. There may be proliferation of
pericytic myoepithelial cells. The intravascular cells are positive for CD31, and
CD34 but negative for HHV-8. In addition, intravascular cells will be positive for
Ulex Europeus and factor VIII-associated antigen supporting an endothelial origin.

STUDIES: Vascular study of abdominal aorta and iliac arteries reveals aorta to

be patent and normal in caliber with mild diffuse arterial occlusive disease noted,
elevate velocities suggest a 50 to 75% stenosis in the mid right external iliac
artery with stent, high grade stenosis versus occlusion of the left iliac artery with
reconstitution of the distal external iliac artery.

BIOPSY: Cleveland Clinic (S18-27479, 2/27/2018) Left thigh: “poorly-

demarcated dermal-based proliferation of poorly formed slit like vascular spaces
which percolate through reticular collagen bundles, surround adnexal structures
and extend into the subcutis. The vascular spaces are lined with flattened, bland
endothelial cells without cytologic atypia or mitotic activity. CD31 and 34 stains
reveal a patchy proliferation of capillaries scattered throughout the dermis. HHV8
stain, to rule out Kaposi ’s sarcoma, is negative.”
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While the pathogenesis is unknown, changes in portal and systemic
hemodynamics as well as a response to local hypoxia have been reported. This is
further supported by the cases of RAE that improve after arterial bypass
procedures, corroborating the notion that local tissue hypoxia may have been an
inciting agent leading to induction of angiogenesis. Another theory is that deposition
of complement and immunoglobulins may induce vascular injury. Furthermore,
association with underlying systemic infections suggest that RAE can represent a
hypersensitivy response of endothelial cells to foreign antigens. This
hypersensitivity response leads to deposition of immunoglobulins in capillaries in the
skin leading to thrombi and ensuing local hypoxia.

Figure C. H&E at 20x. Flattened endothelial cells without
cytologic atypia or mitotic activity.

Figure D. CD34 stain showing patchy proliferation of capillaries
throughout the dermis.
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Other important clinical entities to consider include Kaposi’s Sarcoma and
angiosarcoma. Prognosis of RAE is generally good and characterized by
self-limited disease. Therapy, if needed, is directed at the underlying systemic
disease. However, no specific treatment is currently available. Consideration
can be made for antibiotics for infections and systemic steroids for their
suppressive role on neoangiogenesis when no apparent cause can be found.
In all, RAE is a rare disease related to a reactive endothelial proliferation in
response to an unknown stimulus.
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